Sherrill EH, Sherif BN, Amonkar MM, Wu Y, Maltzman J, O'Rourke L, Johnston S. Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib plus letrozole as first-line therapy in hormone receptor positive, HER2+ metastatic breast cancer (MBC). Poster presented at the ASCO Breast Cancer Symposium; 2009.